Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D A Vuitton

Showing results (11-20 of 108) with videos related to

Pageof 11
Sort By:
La Revue De Medecine Interne|November 26, 1999
[Psychoimmunology: a questionable model?]D A Vuitton, B de Wazières, J L Dupond
Parasite Immunology|May 8, 1998
In vivo treatment with recombinant IL-12 protects C57BL/6J mice against secondary alveolar echinococcosisI Emery, C Leclerc, K Sengphommachanh, et al.
Lancet (London, England)|March 3, 1998
Nosocomial transmission of dengue from a needlestick injuryB de Wazières, H Gil, D A Vuitton, et al.
International Journal for Parasitology|January 9, 1998
Lack of H-2 gene influence on mouse susceptibility to secondary alveolar echinococcosisI Emery, C Leclerc, R Houin, et al.
Clinical and Experimental Rheumatology|July 20, 1999
Treatment of recurrent oro-genital ulceration with low doses of thalidomideB De Wazières, H Gil, D A Vuitton, et al.
Clinical and Experimental Immunology|October 1, 1985
Gall bladder: the predominant source of bile IgA in man?D A Vuitton, E Seilles, P Claude, et al.
Parasite (Paris, France)|October 17, 1998
Echinococcus multilocularis infection in mice: in vivo treatment with a low dose of IFN-gamma decreases metacestode growth and liver fibrogenesisM Liance, S Ricard-Blum, I Emery, et al.
Parasitology Research|September 25, 1998
Echinococcus multilocularis: relationship between susceptibility/resistance and liver fibrogenesis in experimental miceS Guerret, D A Vuitton, M Liance, et al.
Gastroenterologie Clinique Et Biologique|January 1, 1997
[Immediate allergy to anesthetics of the amide group]Y Bourezane, B Adessi, J M Didier, et al.
Gastroenterologie Clinique Et Biologique|January 1, 1997
[Efficacy of lamivudine on the replication of hepatitis B virus in a patient with acquired immunodeficiency syndrome]H Gil, D A Vuitton, A Rozenbaum, et al.
Pageof 11

Showing results (11-20 of 108) with videos related to

Sort By:
Pageof 11
La Revue De Medecine Interne|November 26, 1999
[Psychoimmunology: a questionable model?]D A Vuitton, B de Wazières, J L Dupond
Parasite Immunology|May 8, 1998
In vivo treatment with recombinant IL-12 protects C57BL/6J mice against secondary alveolar echinococcosisI Emery, C Leclerc, K Sengphommachanh, et al.
Lancet (London, England)|March 3, 1998
Nosocomial transmission of dengue from a needlestick injuryB de Wazières, H Gil, D A Vuitton, et al.
International Journal for Parasitology|January 9, 1998
Lack of H-2 gene influence on mouse susceptibility to secondary alveolar echinococcosisI Emery, C Leclerc, R Houin, et al.
Clinical and Experimental Rheumatology|July 20, 1999
Treatment of recurrent oro-genital ulceration with low doses of thalidomideB De Wazières, H Gil, D A Vuitton, et al.
Clinical and Experimental Immunology|October 1, 1985
Gall bladder: the predominant source of bile IgA in man?D A Vuitton, E Seilles, P Claude, et al.
Parasite (Paris, France)|October 17, 1998
Echinococcus multilocularis infection in mice: in vivo treatment with a low dose of IFN-gamma decreases metacestode growth and liver fibrogenesisM Liance, S Ricard-Blum, I Emery, et al.
Parasitology Research|September 25, 1998
Echinococcus multilocularis: relationship between susceptibility/resistance and liver fibrogenesis in experimental miceS Guerret, D A Vuitton, M Liance, et al.
Gastroenterologie Clinique Et Biologique|January 1, 1997
[Immediate allergy to anesthetics of the amide group]Y Bourezane, B Adessi, J M Didier, et al.
Gastroenterologie Clinique Et Biologique|January 1, 1997
[Efficacy of lamivudine on the replication of hepatitis B virus in a patient with acquired immunodeficiency syndrome]H Gil, D A Vuitton, A Rozenbaum, et al.
Pageof 11